ArticleActa parasitologica2025
In Vitro and In Silico Anticoccidial Activity of Opuntia ficus-indica Seed Oil and Hexane Extract: Comprehensive GC-MS Profiling and Mechanistic Insights.
Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The anticoccidial potential of Opuntia ficus-indica seed oil (OFI-SO) and its hexane extract from seed press cake (OFI-HexPC) was evaluated against Eimeria spp. using integrated in vitro and in silico approaches. Sporulated Eimeria oocysts were exposed to increasing concentrations (2-64 mg/mL) of OFI-SO and OFI-HexPC in Hank's balanced salt solution. Oocyst viability was determined by microscopic counting, while membrane integrity was assessed by quantifying the release of 273 nm-absorbing substances. Toltrazuril (25 mg/mL) was used as a positive control. GC-MS profiling of both extracts revealed linoleic acid (54.2%) and oleic acid (25.7%) as the main bioactive fatty acids. GC-MS profiling revealed that linoleic acid (69.63%) was the major fatty acid in OFI-SO, while oleic acid (44.20%) predominated in OFI-HexPC. Both OFI-SO and OFI-HexPC significantly reduced oocyst counts and induced a dose-dependent increase in DNA release. In silico molecular docking was performed against three key Eimeria enzymes (EtDHODH, CDPK, and PKA). Identified fatty acids showed moderate binding affinities through hydrophobic interactions. Redocking validation (RMSD < 2 Å) confirmed the reliability of the docking protocol. ADMET predictions indicated favorable pharmacokinetics and safety profiles. These findings suggest that OFI-SO and OFI-HexPC act via a dual mechanism involving membrane disruption and enzymatic inhibition, supporting their potential as natural alternatives to synthetic anticoccidials in poultry production.
Indexed as
Identifiers
41099938What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.